Liquid biopsy cancer testing - Insights
Learn how the pioneering approach used in liquid biopsy testing available through Mayo Clinic Laboratories enables individualized insights that drive personalized care.
IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) - Insights
In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53...
Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury. Based on the etiology of MPGN, Drs. Sethi and Fervenza proposed a new histologic classification of MPGN into Ig/IC-mediated MPGN and complement-mediated...
MCL Quantitative CMV Immune Competence Assay Patient Information MC1235121
MCL Quantitative CMV Immune Competence Assay Patient Information Complete print Reset Form Quantitative CMV Immune Competence Assay Patient Information CMVC8 Cytomegalovirus CMV CD8 Cell Immune Competence
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 14 - Insights
This week’s Research Roundup highlights how human gut-derived commensal bacteria suppresses central nervous system inflammatory and demyelinating disease.
Microlearning: All the Small Things - Insights
As the saying often goes, “It’s the small things that matter the most.” Jeremy Zacher, Education Specialist in the Department of Laboratory Medicine and Pathology, discusses "microlearning" as a way of delivering learning content in...
Mayo Clinic Laboratories and Progentec launch lupus advanced biomarker testing services - Insights
As a successful outcome of the collaboration announced in 2023, Progentec’s proprietary biomarker blood tests for the proactive management of systemic lupus erythematosus are now available through Mayo Clinic Laboratories.
CPT codes and LOINC update: November 2023 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of November.
Intestinal Infection Testing - Mayo Clinic Laboratories
The gastrointestinal pathogen panel is a multiplex polymerase chain reaction (PCR) test capable of rapidly and qualitatively detecting DNA or RNA of 22 pathogens (13 bacteria, 5 viruses, and 4 parasites).
New tests launched in February - Insights
In February 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.